Related Experiment Video
Updated: Nov 5, 2025

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
Serum Complement C1q Activity Is Associated With Obstructive Coronary Artery Disease
Shuren Guo1, Xiaohuan Mao2, Xiaohua Li1
1Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Insights
Serum complement C1q activity is elevated in patients with obstructive coronary artery disease (CAD). Higher C1q levels correlate with increased risk of CAD and restenosis after revascularization, indicating its association with obstructive CAD.
Area of Science:
- Cardiovascular Research
- Immunology
- Biomarker Discovery
Background:
- Complement C1q has a complex role in atherosclerosis, with prior studies yielding inconsistent findings on its association with coronary artery disease (CAD).
- This study aimed to clarify the relationship between serum C1q activity and CAD, including stenosis severity, cardiovascular biomarkers, and restenosis risk.
Purpose of the Study:
- To investigate the association between serum complement C1q activity and the presence and severity of obstructive and non-obstructive CAD.
- To explore the correlation of C1q activity with cardiovascular biomarkers and 1-year restenosis rates post-revascularization.
Main Methods:
- A cohort of 956 CAD patients and 677 controls were analyzed.
- Serum C1q activity and various laboratory markers were measured.
- Statistical analysis was performed using SPSS22.0.
Main Results:
- Serum C1q activity was significantly higher in both obstructive and non-obstructive CAD groups compared to controls.
- Increased C1q activity correlated with higher total cholesterol and triglyceride levels.
- C1q activity was linked to an increased risk of CAD and 1-year restenosis, but not Gensini score after adjustments.
Conclusions:
- Serum complement C1q activity is associated with obstructive CAD.
- Elevated C1q activity may serve as a predictive marker for restenosis after coronary revascularization.
Abstract:
Background: Complement C1q plays a dual role in the atherosclerosis. Previous studies showed inconsistent results about the association of serum C1q levels and coronary artery disease (CAD). Here, we explored the associations of serum C1q activity with CAD, coronary stenosis severity, cardiovascular biomarkers, and 1-year restenosis after coronary artery revascularization. Methods: We enrolled 956 CAD patients and 677 controls to evaluate the associations of serum complement C1q activity to the presence and severity of obstructive CAD and non-obstructive CAD. Serum C1q activity and the concentrations of laboratory markers were measured in all subjects. All the data were analyzed using SPSS22.0 software. Results: Serum C1q activity in Obstructive CAD and Non-Obstructive CAD groups was significantly higher than the control group (195.52 ± 48.31 kU/L and 195.42 ± 51.25 kU/L vs. 183.44 ± 31.75 kU/L, P < 0.05). Greater C1q activity was significantly correlated with higher total cholesterol (TC) and triglyceride (TG) levels. C1q activity was associated with an increased Odds Ratio (OR) of CAD (OR = 1.322, 95% CI 1.168-1.496, P < 0.05) and 1-year restenosis after revascularization (the highest OR = 3.544, 95% CI 1.089-12.702, P < 0.05). Complement C1q activity was not correlated with Gensini score in the Obstructive CAD group after adjustment for confounders. C1q activity has low value in predicting the incidence of CAD. Conclusion: Serum complement C1q activity is associated with obstructive CAD.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction

